Aralast NP Dosage
Generic name: ALPHA-1-PROTEINASE INHIBITOR HUMAN 16mg in 1mL;
Dosage form: injection
Medically reviewed on September 3, 2018.
Dose ranging studies using efficacy endpoints have not been performed.
Chronic Augmentation Therapy
FOR INTRAVENOUS USE ONLY. The recommended dosage of ARALAST NP is 60 mg/kg body weight administered once weekly by intravenous infusion. Each vial of ARALAST NP has the functional activity, as determined by inhibition of porcine pancreatic elastase, stated on the label. Administration of ARALAST NP within three hours after reconstitution is recommended to avoid the potential ill effect of any inadvertent microbial contamination occurring during reconstitution. Discard any unused contents.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Aralast NP (alpha 1-proteinase inhibitor)
- Aralast NP Side Effects
- During Pregnancy
- Pricing & Coupons
- En Español
- Drug class: miscellaneous respiratory agents